CMS's 2027 proposed rule outlines key Medicare Advantage and Part D program updates, codifying Inflation Reduction Act changes, adjusting Star Ratings, and modernizing marketing and risk adjustment frameworks.

OIG report identifies Medicare overpayments for continuous glucose monitors and urges CMS to reduce payment rates, highlighting potential savings.

Explore Georgia's key 2026 legislative changes impacting insurance affordability, state income tax reductions, consumer protections, teledentistry, property regulations, and more.

CMS releases 2027 Medicare Advantage and Part D proposed rule focusing on Star Ratings adjustments, regulatory burden reduction, and program spending projections.

CMS proposes significant updates to Medicare Advantage and Part D programs for 2027, including Star Ratings revisions and increased quality bonuses, impacting Medicare spending and compliance.

Humana appeals CMS over Medicare Advantage star ratings, contesting calculation methods and evaluation processes affecting bonuses and plan ratings.

Hospitals challenge HHS's 340B pilot shifting drug discounts to a rebate system, citing financial risks and regulatory concerns.

CMS plans to change Medicare hospital payment weights methodology using Medicare Advantage data starting FY2029, impacting hospital reimbursement and clinical documentation.

CMS expands Medicare drug price negotiations to 15 more medications starting in 2027, including popular diabetes and weight loss treatments, aiming to reduce prescription costs and save Medicare billions.

CMS unveils the GENERous Medicaid payment model introducing MFN drug pricing, alongside expanded Trump administration drug pricing agreements and key regulatory updates for 2026.